MDR1/P-glycoprotein expression in colorectal cancer

This publication has 24 references indexed in Scilit:

• p53 Status and the Efficacy of Cancer Therapy in Vivo
  Science, 1994
• Complete remission of metastatic colorectal cancer: a pitfall in a multidrug resistance reversal trial
  The Lancet, 1994
• Phase II study of d-verapamil and doxorubicin in patients with metastatic colorectal cancer
  European Journal Of Cancer, 1993
• p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
  Cell, 1993
• Various Methods of Analysis of mdr-1/P-Glycoprotein in Human Colon Cancer Cell Lines
  JNCI Journal of the National Cancer Institute, 1992
• Modulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53
  Science, 1992
• P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma
  New England Journal of Medicine, 1991
• Multidrug resistance from the clinical point of view
  European Journal of Cancer and Clinical Oncology, 1991
• Doxorubicin in Combination with Verapamil in Advanced Colorectal Cancer: A Phase It Trial
  Acta Oncologica, 1991
• Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.
  Journal of Histochemistry & Cytochemistry, 1990